Tudor Investment Corp
TCRT icon

Tudor Investment Corp’s Alaunos Therapeutics TCRT Stock Holding History

Tudor Investment Corp’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-262
Closed -$2.78K – 2771
2023
Q4 		$2.78K Hold
262
– – ﹤0.01% 2294
2023
Q3 		$5.19K Hold
262
– – ﹤0.01% 2218
2023
Q2 		$20.1K Hold
262
– – ﹤0.01% 2338
2023
Q1 		$25K Hold
262
– – ﹤0.01% 2306
2022
Q4 		$26K Hold
262
– – ﹤0.01% 2261
2022
Q3 		$68K Sell
262
-1,947
-88% -$566K ﹤0.01% 2172
2022
Q2 		$411K Hold
2,209
– – 0.01% 1389
2022
Q1 		$216K Hold
2,209
– – 0.01% 1723
2021
Q4 		$361K Hold
2,209
– – 0.01% 1707
2021
Q3 		$603K Buy
2,209
+1,862
+537% +$569K 0.01% 1531
2021
Q2 		$138K Buy
+347
New +$162K ﹤0.01% 1517
2021
Q1 		– Sell
-1,812
Closed -$685K – 1844
2020
Q4 		$685K Sell
1,812
-478
-21% -$190K 0.02% 832
2020
Q3 		$866K Buy
2,290
+1,895
+480% +$837K 0.04% 613
2020
Q2 		$194K Sell
395
-451
-53% -$201K 0.01% 1028
2020
Q1 		$311K Buy
+846
New +$438K 0.03% 681
2018
Q1 		– Sell
-107
Closed -$66K – 1237
2017
Q4 		$66K Sell
107
-225
-68% -$162K ﹤0.01% 1039
2017
Q3 		$306K Sell
332
-90
-21% -$79.9K 0.01% 821
2017
Q2 		$394K Buy
422
+336
+391% +$329K 0.01% 660
2017
Q1 		$82K Buy
+86
New +$80.1K ﹤0.01% 1318
2016
Q4 		– Sell
-112
Closed -$94K – 1603
2016
Q3 		$94K Sell
112
-62
-36% -$49.8K ﹤0.01% 1343
2016
Q2 		$143K Buy
174
+16
+10% +$17.4K ﹤0.01% 1470
2016
Q1 		$176K Sell
158
-177
-53% -$181K ﹤0.01% 1531
2015
Q4 		$417K Sell
335
-28
-8% -$46.3K 0.01% 1014
2015
Q3 		$490K Buy
363
+213
+142% +$352K 0.02% 792
2015
Q2 		$269K Sell
150
-31
-17% -$48.1K 0.01% 1170
2015
Q1 		$293K Buy
181
+10
+6% +$14.8K 0.01% 1066
2014
Q4 		$130K Buy
171
+41
+32% +$21.8K ﹤0.01% 1346
2014
Q3 		$52K Buy
+130
New +$62.7K ﹤0.01% 1300
2014
Q2 		– Sell
-132
Closed -$91K – 1319
2014
Q1 		$91K Sell
132
-49
-27% -$32.8K ﹤0.01% 1132
2013
Q4 		$118K Buy
181
+60
+50% +$35.7K 0.01% 1191
2013
Q3 		$72K Sell
121
-46
-28% -$20.7K ﹤0.01% 779
2013
Q2 		$53K Buy
+167
New +$46.4K ﹤0.01% 773

Other funds holding TCRT

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
Allred Capital Management Dallas, Texas $275M AUM 18.19% 1-Year Est. Return

Tudor Investment Corp's TCRT Position: Q1 2024 in Review

Tudor Investment Corp sold out of Alaunos Therapeutics (TCRT) in Q1 2024, closing a stake of 262 shares — an estimated $2.78K sold.

Tudor Investment Corp first reported a position in TCRT in Q2 2013 and held it in 32 quarters. The position peaked at $866K in Q3 2020. 45 funds tracked by Wall St. Rank hold TCRT as of Q1 2024.

  • Tudor Investment Corp reported no remaining Alaunos Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Tudor Investment Corp sold 262 Alaunos Therapeutics shares in Q1 2024, an estimated $2.78K.
  • Tudor Investment Corp first reported a position in Alaunos Therapeutics in Q2 2013 and held it in 32 quarters.
  • Tudor Investment Corp's Alaunos Therapeutics position peaked at $866K in Q3 2020.
  • 45 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2024.

Based on Tudor Investment Corp's 13F filing for Q1 2024, filed 15 May 2024.